Although the wide range of biological mechanisms in which SIRT1 and VDR are involved makes it difficult to consider them as potential specific diagnostic and prognostic biomarkers of DN, their observed alteration in the blood of patients with neuropathy certainly provides a new small step in the understanding of this condition. The gene discussed is VDR; the disease is liver dysplastic nodule.